Merck to shut down clinical chemistry:
This article was originally published in Clinica
German company Merck KGaA is to shut down its declining clinical chemistry business and concentrate on immunodiagnostics. Sales in clinical chemistry represent around 40% of diagnostics turnover of DM 272 million ($190 million) in 1995. Merck will continue to provide service and the necessary test-kits for existing systems in the market.